Denver, Colorado, United States In 1999 was created Sphera Corporation, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The leading representative office of defined Corporate Investor is situated in the Denver.
The common things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2013. The increased amount of exits for fund were in 2015.
The typical case for the fund is to invest in rounds with 2 participants. The meaningful sponsors for the fund in investment in the same round are Gabriel Capital Management. In the next rounds fund is usually obtained by ROTH Capital Partners, Oppenheimer & Co., Inc., Ladenburg Thalmann.
The fund was created by Avishai Abrahami, Roy Saar.
Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Intec Pharma. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Israel. Among the most successful fund investment fields, there are Health Care, Biotechnology.
| Fund Name | Location |
| Accordance Ventures LP. | - |
| ACF Equity Atlantic | Canada, Halifax, Nova Scotia |
| AET | Japan, Kanagawa Prefecture, Kawasaki |
| Beijing Zhong Jinwanwei Touzi Guanli Zhongxin (Youxian Hehuo) | Beijing, Beijing, China |
| Cross Pacific Capital Partners | British Columbia, Canada, Vancouver |
| DF International Partners | - |
| Dingju Touzi | China, Guangdong, Shenzhen |
| EasyParcel | Malaysia, Penang, Pulau Pinang |
| ENRICH | Boston, Massachusetts, United States |
| GreenSky Capital | Canada, Ontario, Toronto |
| Guochuang Medical | China, Shanghai |
| Haselmeier | Baden-Wurttemberg, Germany, Stuttgart |
| JS Capital | Japan, Niigata, Niigata Prefecture |
| LMK Ventures | - |
| Maschinenfabrik Reinhausen | - |
| MKS Ventures | Canada, Ontario, Toronto |
| Nest | China, Hong Kong, Hong Kong Island |
| Opea Holding | - |
| Phase4 Partners | England, London, United Kingdom |
| Swiss Life | Switzerland, Zürich, Zurich |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Intec Pharma | $5M | 19 Aug 2013 | Jerusalem District |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Intec Pharma | $5M | 19 Aug 2013 | Jerusalem District |
